ACC: Enalapril + Folic Acid Cuts Stroke Risk in Hypertension

This article originally appeared here.
Share this content:
ACC: Enalapril + Folic Acid Cuts Stroke Risk in Hypertension
ACC: Enalapril + Folic Acid Cuts Stroke Risk in Hypertension

(HealthDay News) -- For patients with hypertension, the combined use of enalapril and folic acid is associated with reduced risk of first stroke, according to a study published online March 15 in the Journal of the American Medical Association. The research was published to coincide with its presentation at the annual meeting of the American College of Cardiology, held from March 14 to 16 in San Diego.

Yong Huo, M.D., from the Peking University First Hospital in Beijing, and colleagues examined whether enalapril plus folic acid is more effective in reducing first stroke than enalapril alone. Data were included for 20,702 adults with hypertension without history of stroke or myocardial infarction (MI). The participants were randomized to receive a single pill combination containing enalapril and folic acid (10,348 participants) or a tablet with enalapril alone (10,354 participants).

The researchers found that the enalapril-folic acid group had a significant risk reduction in first stroke compared with the enalapril alone group (2.7 versus 3.4 percent; hazard ratio, 0.79) during a median treatment duration of 4.5 years. The enalapril-folic acid group also had reduced risk of first ischemic stroke (hazard ratio, 0.76) and composite cardiovascular events consisting of cardiovascular death, MI, and stroke (hazard ratio, 0.80). There were no significant between-group differences noted in the risk of hemorrhagic stroke, MI, and all-cause deaths.

"These findings are consistent with benefits from folate use among adults with hypertension and low baseline folate levels," the authors write.

Several authors disclosed financial ties to Shenzhen AUSA Pharmed, which partially funded the trial.

Abstract
Full Text
Editorial
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ancient Gene Protects Elephants From Cancer

Ancient Gene Protects Elephants From Cancer

The LIF6 gene destroys cells with damaged DNA

Reasons for Undergoing Cosmetic Procedures Explored

Reasons for Undergoing Cosmetic Procedures Explored

Psychological and emotional motivations more likely in patients wanting acne scar tx, tattoo removal

DNR Orders Linked to Increased Mortality in Older Adults

DNR Orders Linked to Increased Mortality in Older ...

Early versus late DNR tied to shorter median length of stay in hospitalized adults aged 65 years and older

is free, fast, and customized just for you!




Already a member?

Sign In Now »